Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...

Just eight seconds into the start of the 2025 award show season, Nikki Glaser, the host of the 82nd Golden Globes, dubbed the ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

But it is not necessarily the same thing as cost-saving. And in the case of the latest wave of weight loss drugs, right now at their current prices they are not even cost-effective, let alone cost ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The study stated that weight loss drugs can affect bone and muscle mass, leading to chronic illnesses and risk of fractures. For the longest time, people resorted to diet and exercise for losing ...

It’s no wonder then that a newer class of highly-effective weight-loss drugs, known commonly as GLP-1 or incretin treatments have taken the country by storm. Analysts at Morgan Stanley project ...

Here is one for him: Keep President Joe Biden’s commitment to have Medicare pay for GLP-1 drugs such as Ozempic and Wegovy for weight loss. But only if the drugmakers agree to substantially ...

The two met in 2022 through a TikTok GLP-1 community soon after they started using the weight loss drugs. “We’re each other’s biggest cheerleader,” says Doty. “I don’t know anybody ...

In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers unprecedented hope. Drugs like semaglutide (Wegovy ...